Haruhiko Kuno

Platelet‐like particle formation in the human megakaryoblastic leukaemia cell lines, MEG‐01 and MEG‐01s

Kikuko Takeuchi, Motonobu Satoh, Haruhiko Kuno et al. · British Journal of Haematology · 1998 · 63 citations · Full text

Medicine, Cell Biology, Hematology +17

Discovery of Novel, Highly Potent, and Selective Quinazoline-2-carboxamide-Based Matrix Metalloproteinase (MMP)-13 Inhibitors without a Zinc Binding Group Using a Structure-Based Design Approach

Hiroshi Nara, Kenjiro Sato, Takako Naito et al. · Journal of Medicinal Chemistry · 2014 · 59 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +12

Discovery of Novel, Highly Potent, and Selective Matrix Metalloproteinase (MMP)-13 Inhibitors with a 1,2,4-Triazol-3-yl Moiety as a Zinc Binding Group Using a Structure-Based Design Approach

Hiroshi Nara, Akira Kaieda, Kenjiro Sato et al. · Journal of Medicinal Chemistry · 2016 · 56 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Cytokines affecting survival and differentiation of an astrocyte progenitor cell line

Touho Yoshida, Motonobu Satoh, Yumiko Nakagaito et al. · Developmental Brain Research · 1993 · 51 citations

Life Sciences, Cell Biology, Developmental Biology +12

Thieno[2,3-d]pyrimidine-2-carboxamides bearing a carboxybenzene group at 5-position: Highly potent, selective, and orally available MMP-13 inhibitors interacting with the S1″ binding site

Hiroshi Nara, Kenjiro Sato, Takako Naito et al. · Bioorganic & Medicinal Chemistry · 2014 · 50 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +13